YOLFTbeta
iTonic Holdings Ltd.

iTonic Holdings Ltd.

ITOC · NASDAQ · Healthcare / Medical Devices

1.98USD+0.08 (+4.21%)

Price History

Full chart

Market Stats

Previous Close1.90
Open1.97
Day Range1.80 – 2.10
52-Week Range0.219 – 1.09
Volume33.85K
Market Cap7.19M
P/E (TTM)0.00
Forward P/E0.00
EPS-0.32
Dividend Yield0.00%
Beta2.77
50-Day Avg0.2926
200-Day Avg0.3576

About

iTonic Holdings Ltd., a healthcare solutions provider, develops and commercializes treatment software and devices used for brachytherapy. The company's proprietary treatment planning system is a radioactive particle implantation, a radiotherapy used in treating cancer patients by placing radioactive sources inside the patient that kill cancer cells and shrink tumors. The company offers FTTPS, a treatment planning system for treating various malignant tumors, which could determine the target volume, prescription dose, and dose limitation to protect organs at risks and produce a safe, effective, and accurate dose distribution plan for brachytherapy for cancer patients. The company was formerly known as Pheton Holdings Ltd and changed its name to iTonic Holdings Ltd. in January 2026. iTonic Holdings Ltd. was founded in 1998 and is headquartered in Beijing, China. iTonic Holdings Ltd. operates as a subsidiary of ZJW (BVI) LTD.

Company Details

  • SectorHealthcare
  • IndustryMedical Devices
  • CEOMr. Jianfei Zhang
  • Employees7
  • HeadquartersNET Building, Beijing, China, 100101, USA
  • Websitehttps://www.ftzy.com.cn

Leadership

  • Mr. Jianfei ZhangCEO & Chairman of the Board · b. 1972
  • Ms. Simin TanChief Financial Officer · b. 1995

Financials

Income Statement

Currency: USD2021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue702.78K679.78K628.59K448.20K523.03K
Growth (%)--3.27%-7.53%-28.70%+16.70%
Cost of Revenue112.03K121.63K157.76K103.26K195.68K
Gross Profit590.74K558.15K470.83K344.94K327.35K
Gross Margin84.06%82.11%74.90%76.96%62.59%
Operating Expense452.66K530.63K777.51K1.12M5.51M
Operating Income138.09K27.52K-306.68K-770.27K-5.19M
Operating Margin19.65%4.05%-48.79%-171.86%-991.71%
EBITDA269.48K125.11K-197.38K-566.33K-5.17M
EBITDA Margin38.34%18.41%-31.40%-126.36%-989.17%
Net Income192.46K83.98K-241.22K-660.59K-5.10M
Net Income Margin27.39%12.35%-38.37%-147.39%-974.68%
R&D81.22K73.72K84.47K93.32K459.13K
R&D as % of Total Revenue11.56%10.84%13.44%20.82%87.78%

Balance Sheet

Currency: USD2021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets1.33M1.40M1.62M6.72M9.10M
Total Liabilities376.65K845.41K1.32M538.55K969.83K
Total Equity954.34K556.32K306.27K6.18M6.12M
Cash136.75K72.29K227.45K6.16M1.49M
Total Debt297.40K218.33K155.82K247.97K143.00K
Net Debt160.65K146.04K-71.63K-5.91M-1.35M

Cash Flow

Currency: USD2021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow80.77K-116.15K-63.64K-775.00K-3.24M
Investing Cash Flow----861-1.35M
Financing Cash Flow-72.82K78.14K220.59K6.71M-82.74K
Capital Expenditure5248593.81K
Free Cash Flow80.77K-116.15K-63.64K-775.86K-3.24M
Dividends Paid0398.44K000
FCF to OCF100.01%100.00%100.01%100.11%100.12%
Dividend Paid to FCF0.00%-343.04%0.00%0.00%0.00%

Earnings

Report DateMar 20, 2025Dec 16, 2025
EPS Estimate0.000.00
EPS Actual-0.03-0.14
Surprise--
Timing--

Key Statistics & Ratios

Market Cap7.19M
Enterprise Value2.66M
Trailing P/E0.00
Forward P/E0.00
Price / Sales13.74
Price / Book0.89
EPS-0.32
Book Value0.359
Revenue (TTM)523.03K
Gross Profit (TTM)327.35K
EBITDA-5.17M
Profit Margin0.00%
Operating Margin-681.94%
Return on Equity-71.25%
Return on Assets-40.99%
Shares Outstanding9.38M
Shares Float15.64M
Beta2.77
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Ownership Breakdown

Institutions
0.26%
Insiders
1.82%
Retail / Other
97.92%

Top Institutional Holders

  • XTX Topco Ltd
    48.33K0.04%
  • Citadel Advisors Llc
    43.38K0.04%
  • Point72 Asset Management, L.P.
    10.85K0.01%
  • Cygnus Capital Advisors, LLC
    5.25K0.00%
  • NATIONAL BANK OF CANADA /FI/
    1.80K0.00%
  • BlackRock Inc
    6180.00%
  • Morgan Stanley - Brokerage Accounts
    4730.00%
  • Compagnie Lombard, Odier SCA
    1400.00%
  • Two Sigma Investments LLC
    00.00%
  • TWO SIGMA SECURITIES, LLC
    00.00%
  • UBS Group AG
    00.00%

Top Fund Holders

  • BSF Systematic US Eq Abs Ret A2 USD
    7800.00%